Renal Cancer - Results from #680

Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma. October 17, 2023

18F-fluoro-2-deoxy-2-d-glucose PET-CT (FDG PET-CT) in staging of high-risk renal and urothelial bladder cancers (COPPER-T) trial protocol. October 16, 2023

2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race. October 16, 2023

Adverse Events of Cabozantinib Plus Nivolumab Versus Ipilimumab Plus Nivolumab. October 13, 2023

An Updated Systematic Review and Meta-Analysis on the Technical, Oncologic, and Safety Outcomes of Microwave Ablation in Patients with Renal Cell Carcinoma. October 13, 2023

Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era. October 12, 2023

Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions. October 12, 2023

Multiphase CT radiomics nomogram for preoperatively predicting the WHO/ISUP nuclear grade of small (< 4 cm) clear cell renal cell carcinoma. October 11, 2023

Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass-Intermediate-Term Results. October 11, 2023

Patients with metastatic renal cell carcinoma who receive immune-targeted therapy may derive survival benefit from nephrectomy. October 10, 2023

The National Utilization of Non-Operative Management for Small Renal Masses Over 10 Years. October 10, 2023

Evaluation of local control after percutaneous microwave ablation versus partial nephrectomy: A propensity score matched study. October 9, 2023

Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment. October 9, 2023

Identification of KIFC1 as an independent prognostic marker in renal clear cell carcinoma correlates with tumor proliferation and immune infiltration. October 6, 2023

Cellular specificity of lactate metabolism and a novel lactate-related gene pair index for frontline treatment in clear cell renal cell carcinoma. October 6, 2023

Effect of Stereotactic Body Radiotherapy on the Growth Kinetics and Enhancement Pattern of Primary Renal Tumors. October 6, 2023

Diagnostic miRNA Signatures in Paired Tumor, Plasma, and Urine Specimens From Renal Cell Carcinoma Patients. October 5, 2023

Systemic Treatment for Advanced and Metastatic Non-Clear Cell Renal Cell Carcinoma: Examining Modern Therapeutic Strategies for a Notoriously Challenging Malignancy. October 5, 2023

Evaluation of Volumetric Response Assessment from Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Carcinoma (RCC). October 4, 2023

Outcomes of Targeted Therapy Plus Immunotherapy and High-Dose Stereotactic Ablative Body Radiotherapy (SABR) for Metastatic Renal Cell Cancer Patients. October 4, 2023

Page 35 of 455